[go: up one dir, main page]

GB201004304D0 - Biomarkers for prostate cancer - Google Patents

Biomarkers for prostate cancer

Info

Publication number
GB201004304D0
GB201004304D0 GBGB1004304.0A GB201004304A GB201004304D0 GB 201004304 D0 GB201004304 D0 GB 201004304D0 GB 201004304 A GB201004304 A GB 201004304A GB 201004304 D0 GB201004304 D0 GB 201004304D0
Authority
GB
United Kingdom
Prior art keywords
biomarkers
prostate cancer
prostate
cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GBGB1004304.0A
Other versions
GB2478734A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sense Proteomic Ltd
Original Assignee
Sense Proteomic Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sense Proteomic Ltd filed Critical Sense Proteomic Ltd
Priority to GB1004304A priority Critical patent/GB2478734A/en
Publication of GB201004304D0 publication Critical patent/GB201004304D0/en
Priority to PCT/GB2011/050489 priority patent/WO2011114139A1/en
Publication of GB2478734A publication Critical patent/GB2478734A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • CCHEMISTRY; METALLURGY
    • C40COMBINATORIAL TECHNOLOGY
    • C40BCOMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B40/00Libraries per se, e.g. arrays, mixtures
    • C40B40/04Libraries containing only organic compounds
    • C40B40/10Libraries containing peptides or polypeptides, or derivatives thereof
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407Specifically defined cancers
    • G01N33/57434Specifically defined cancers of prostate
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57488Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds identifable in body fluids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Rehabilitation Therapy (AREA)
  • Rheumatology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
GB1004304A 2010-03-15 2010-03-15 Auto-antibody biomarkers of prostate cancer Withdrawn GB2478734A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GB1004304A GB2478734A (en) 2010-03-15 2010-03-15 Auto-antibody biomarkers of prostate cancer
PCT/GB2011/050489 WO2011114139A1 (en) 2010-03-15 2011-03-11 Auto-antigen biomarkers for prostate cancer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB1004304A GB2478734A (en) 2010-03-15 2010-03-15 Auto-antibody biomarkers of prostate cancer

Publications (2)

Publication Number Publication Date
GB201004304D0 true GB201004304D0 (en) 2010-04-28
GB2478734A GB2478734A (en) 2011-09-21

Family

ID=42261619

Family Applications (1)

Application Number Title Priority Date Filing Date
GB1004304A Withdrawn GB2478734A (en) 2010-03-15 2010-03-15 Auto-antibody biomarkers of prostate cancer

Country Status (2)

Country Link
GB (1) GB2478734A (en)
WO (1) WO2011114139A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113721031A (en) * 2021-08-30 2021-11-30 河南中医药大学 Serum-related autoantibody marker for auxiliary diagnosis of hashimoto thyroiditis and application thereof

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201017520D0 (en) * 2010-10-15 2010-12-01 Sense Proteomic Ltd Biomarkers
SG10201908922UA (en) * 2019-09-25 2021-04-29 Sengenics Corp Pte Ltd Identification of health status in the elderly using immunological biomarkers
CN119881317B (en) * 2025-03-25 2025-07-04 德州学院 Paper chip for simultaneously detecting multiple prostate cancer markers and preparation method and application thereof

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1004304A (en) 1963-08-20 1965-09-15 Jeffrey Hulme Manufacture of pottery
WO2001057198A2 (en) 2000-01-31 2001-08-09 Sense Proteomic Limited Methods of generating protein expression arrays and the use thereof in rapid screening
JP2003522962A (en) 2000-02-16 2003-07-29 クァンタム・ドット・コーポレイション Microarray method using semiconductor nanocrystals
JP2004509645A (en) 2000-08-17 2004-04-02 センス・プロテオミック・リミテッド Method
US20090226915A1 (en) 2001-01-24 2009-09-10 Health Discovery Corporation Methods for Screening, Predicting and Monitoring Prostate Cancer
SE0100595D0 (en) * 2001-02-22 2001-02-22 Lena Carlsson Immunological detection of prostate diseases and prostatic-related diseases
GB0202018D0 (en) 2002-01-29 2002-03-13 Sense Proteomic Ltd Tag and method
US20030224462A1 (en) * 2002-06-04 2003-12-04 Parsons George H. Immunoassay for cancer
DE60315343T2 (en) 2002-10-25 2008-04-17 Sense Proteomic Ltd., Maidenhead NOVEL USES OF BLE GENES PROTEINS AND ANTIBIOTICS FROM THE BLEOMYCIN FAMILY
US20080081339A1 (en) 2006-10-03 2008-04-03 The Brigham And Women's Hospital, Inc. Tumor associated markers in the diagnosis of prostate cancer
WO2008061104A2 (en) * 2006-11-13 2008-05-22 Invitrogen Corporation Methods and kits for detecting prostate cancer biomarkers
EP1921149A1 (en) * 2006-11-13 2008-05-14 AEterna Zentaris GmbH Microorganisms as carriers of nucleotide sequences coding for antigens and protein toxins, process of manufacturing and uses thereof
MX2009010910A (en) * 2007-04-12 2010-01-20 Proteosys Ag Autoimmune regulation of prostate cancer by annexin a3.
US7981625B2 (en) 2008-04-15 2011-07-19 The Board Of Trustees Of The Leland Stanford Junior University Prostate cancer glycan markers and autoantibody signatures

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113721031A (en) * 2021-08-30 2021-11-30 河南中医药大学 Serum-related autoantibody marker for auxiliary diagnosis of hashimoto thyroiditis and application thereof
CN113721031B (en) * 2021-08-30 2024-02-13 河南中医药大学 Serum-related autoantibody marker for assisting diagnosis of hashimoto thyroiditis and application thereof

Also Published As

Publication number Publication date
GB2478734A (en) 2011-09-21
WO2011114139A1 (en) 2011-09-22

Similar Documents

Publication Publication Date Title
EP2718721A4 (en) Circulating biomarkers for cancer
IL229319A0 (en) Biomarkers for lung cancer
PL2576837T3 (en) Prostate cancer associated circulating nucleic acid biomarkers
SG2014007454A (en) Pancreatic cancer biomarkers and uses thereof
EP2625292A4 (en) CANCER BIOMARKERS
WO2011163332A9 (en) Methods for detecting cancer
GB201016139D0 (en) Cancer phosholipidome
PL2931922T3 (en) Personalized biomarkers for cancer
EP2550631A4 (en) Mobile payments
WO2012012225A9 (en) Predicting cancer outcome
GB201012590D0 (en) Methods for diagnosing cancer
GB201021502D0 (en) Biomarkers
EP2831270B8 (en) Biomarker for bladder cancer
GB201008340D0 (en) Biomarkers
ZA201703026B (en) Biomarkers for the prediction of incident cancer
GB201018056D0 (en) Biomarkers
WO2012167112A9 (en) Gastric cancer biomarkers
EP2707721A4 (en) Predictive biomarkers for prostate cancer
GB201004442D0 (en) Biomarker
GB201005561D0 (en) Biomarkers
GB201001444D0 (en) Biomarkers
GB2510539B (en) Biomarkers of cancer
EP2753716A4 (en) Novel risk biomarkers for lung cancer
EP2501845A4 (en) Biomarkers of cancer
GB201010316D0 (en) Biomarkers

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)